Preconceptional health care model

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 78, Issue 2, 1998, Pages 163-168

  Allaire, Alexander D ^a   Cefalo, Robert C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Homocysteine; Infections; Metabolic disease; Organogenesis; Preconception; Vitamins

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; MULTIVITAMIN; VITAMIN;

ADULT; CONFERENCE PAPER; CONGENITAL MALFORMATION; FETUS; HEALTH CARE; HUMAN; MATERNAL CARE; METABOLIC DISORDER; NUTRITION; ORGANOGENESIS; PATIENT COUNSELING; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL CARE; PRIORITY JOURNAL;

EID: 0032104762     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00062-1     Document Type: Conference Paper

References (28)

1. [1] Cefalo RC, Moos MK. Preconceptional health care: A practical guide. St. Louis: Mosby, 1995.
2. [2] Committee on Unintended Pregnancy, Division of Health Promotion and Disease Prevention. Institute of Medicine. The best intentions. Washington, DC, National Academy Press, 1985.
3. [3] Adams MM, Bruce FC, Shulman HB, Kendrick JS, Brogan SJ. The PRAMS Working Group. Pregnancy planning and preconception counseling. Obstet Gynecol 1993;82:955-9.
4. [4] American College of Obstetricians and Gynecologists. Preconceptional Care. ACOG Technical Bulletin Number 205. Washington, DC. 1995.
5. [5] Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Eng J Med 1992;321:430-5.
6. [6] Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrence of neural tube defects. J Am Med Assoc 1993;269:1257-61.
7. [7] Centers for Disease Control: Recommendations for the use of folic acid to reduce the number of spina bifida and other neural tube defects. Morbidity and Mortality Weekly Report 1992; 41: 1-7.
8. [8] Cefalo RC, Bowes WA, Moos MK. Preconception care: A means of prevention. Bailliere's Clin Obstet Gynecol 1995;9:403-16.
9. [9] Clark NA, Fisk NM. Minimal compliance with the department of health recommendation for routine folate prophylaxis to prevent neural tube defects. Br J Obstet Gynecol 1994;101:709-10.
10. [10] Marsack CR, Alsop CL, Kurinczuk JJ, Bower C. Prepregnancy counseling for the primary prevention of birth defects - rubella vaccination and folate intake. Med J Aust 1995;162:403-6.
11. [11] Centers for Disease Control: Knowledge and use of folic acid by women of childbearing age - United States. Morbidity and Mortality Weekly Report 1997; 46: No 31: 721-723.
12. [12] Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, Weir DG, Scott JM. Minimum effective dose of folic acid for food fortification to prevent neural tube defects. Lancet 1997;350:1666-9.
13. [13] Jacobson B. Chapati flour should be fortified as well. Br Med J 1995;311:256.
14. [14] Steegers-Theunissen RP, Boers GH, Trijbels FJ, Eskes TKA. Metabolism 1995;43:1475-80.
15. [15] Steegers-Theunissen RP. Boers GH, Trijbels FJ, Finkelstein JD, Blom HJ, Thomas CM, Borm GF, Wonters MG, Eskes TKA. N Engl J Med 1991; 334: 199-200.
16. [16] Molloy AM, Daly S, Mills JL. Kirke PN, Whitehead AS, Ramsbottom D, Conley MR, Weir DG, Scott LM. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red cell folates:implications for folate intake recommendations. Lancet 1997;349:1591-3.
17. [17] Kirke PN, Molloy AM, Daly LE et al. Quarterly Journal of Medicine l993;86:703-7.
18. [18] Mills JL, McPartin JM, Kirke PN. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995;345:149-51.
19. [19] Gabert HA, von Almen W. Rubella, in: Pastorek JG. editor. Obstetric and Gynecologic Infectious Disease. New York: Raven Press, 1994.
20. [20] Conway T, Mason E, Hu TC. Attitudes, knowledge, and skills of internal medicine residents regarding preconception care. Acad Med 1994;69:389-91.
21. [21] American College of Obstetricians and Gynecologists. Perinatal viral and perinatal infections. ACOG Technical Bulletin 177. Washington, DC. 1993.
22. [22] Siedman DS, Stevenson DK, Arvin AM. Varicella vaccine in pregnancy: routine screening and vaccination should be considered. Br Med J 1996;313:701-2.
23. [23] Duff P. Maternal and perinatal infections in pregnancies. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: Normal and problem pregnancies, 2nd ed. New York: Churchill Livingston. 1996.
24. [24] American College of Obstetrians and Gynecologists. Human immunodeficiency virus in pregnancy. ACOG Educational Bulletin Number 232. Washington, DC; 1997.
25. [25] Cox M, Whittle MJ, Byrne A. Prepregnancy counselling: Experience from 1075 cases. Br J Obstet Gynaecol 1992;99:873-6.
26. [26] Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Mann EK, Zigrang WD. Preconception care of diabetes. Glycemic control prevents congenital anomalies. J Am Med Assoc 1991;265:731-6.
27. [27] Elixhouser A, Weschler JM, Kitsmiller JL, Marks JS, Bennert HW, Coustan DR, Gabbe SG, Herman WH, Kaufmann RC, Ogata ES, Sepe SJ. Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care 1993;16:1146-57.
28. [28] Rodgers BD, Rodgers DE. Efficacy of preconception care of diabetic women in a community setting. J Reprod Med 1996;41:422-6.